The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Steinhart Richard I since year 2005.
The trader's CIK number is 1293789.
At the time of this reporting, Steinhart Richard I is the Chief Financial Officer of Bioxcel Therapeutics, Inc. .
(stock ticker symbol BTAI).
See this page for all insider trading activities at Bioxcel Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-03||BTAI||Bioxcel Therapeutics, Inc.||Buy||500||5.20||2,600|
|2018-11-29||BTAI||Bioxcel Therapeutics, Inc.||Buy||500||5.00||2,500|
|2018-11-30||BTAI||Bioxcel Therapeutics, Inc.||Buy||500||5.00||2,500|
|2016-04-14||ATNM||Actinium Pharmaceuticals, Inc.||Buy||2,500||2.01||5,024|
|2013-06-25||MELA||Strata Skin Sciences, Inc.||Buy||3,000||.81||2,427|
|2010-08-12||MELA||Strata Skin Sciences, Inc.||Buy||1,000||6.32||6,320|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Steinhart Richard I (Chief Financial Officer of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.